Speaker :

Dr. Sujana Priya, Radiation Oncologist, Hyderabad

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre,

non-inferiority, randomised, phase 3 trial

Author: Adrian Murray Brunt

Citation: Lancet.2020 May 23;395(10237):1613-1626

Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early  Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG  HYPO Trial

Author: Birgitte V. Offersen

Citation: Journal of Clinical Oncology 38, no. 31 (November 01, 2020) 3615-3625